首页> 外文期刊>Microbiology >Point mutations in the DNA- and cNMP-binding domains of the homologue of the cAMP receptor protein (CRP) in Mycobacterium bovis BCG: implications for the inactivation of a global regulator and strain attenuation
【24h】

Point mutations in the DNA- and cNMP-binding domains of the homologue of the cAMP receptor protein (CRP) in Mycobacterium bovis BCG: implications for the inactivation of a global regulator and strain attenuation

机译:营养蛋白蛋白(CRP)的DNA-和CNMP结合结构域中的点突变在细胞杆菌BCG中的同源物中:对全局调节剂的失活的影响和应变衰减

获取原文
           

摘要

The genome of Mycobacterium tuberculosis H37Rv includes a homologue of the CRP/FNR (cAMP receptor protein/fumarate and nitrate reduction regulator) family of transcription regulators encoded by Rv3676. Sequencing of the orthologous gene from attenuated Mycobacterium bovis Bacille Calmette–Guérin (BCG) strains revealed point mutations that affect the putative DNA-binding and cNMP-binding domains of the encoded protein. These mutations are not present in the published sequences of the Rv3676 orthologues in M. bovis, M. tuberculosis or Mycobacterium leprae. An Escherichia coli lacZ reporter system was used to show that the M. tuberculosis Rv3676 protein binds to DNA sites for CRP, but this DNA binding was decreased or abolished with the Rv3676 protein counterparts from BCG strains. The DNA-binding ability of the M. tuberculosis Rv3676 protein was decreased by the introduction of base changes corresponding to the BCG point mutations. Conversely, the DNA binding of the BCG Rv3676 proteins from BCG strains was restored by removing the mutations. These data show that in this reporter system the point mutations present in the Rv3676 orthologue in BCG strains render its function defective (early strains) or abolished (late strains) and suggest that this protein might be naturally defective in M. bovis BCG strains. This raises the possibility that a contributing factor to the attenuation of BCG strains may be an inability of this global regulator to control the expression of genes required for in vivo survival and persistence.
机译:结核分枝杆菌H37RV的基因组包括RV3676编码的CRP / FNR(CAMP受体蛋白/富马酸核和硝酸核和硝酸盐还原调节剂)的同源物。从减毒的分枝杆菌Bacis Bacilly-guérin(BCG)菌株的测序显示出影响编码蛋白的推定的DNA结合和CNMP结合结构域的点突变。这些突变不存在于M.Bovis,肺炎菌菌病或麻痹术中的RV3676原干药的公布序列中。估计大肠杆菌Racz报道系统用于表明M.Tuberculosis RV3676蛋白与CRP的DNA位点结合,但是该DNA结合降低或废除来自BCG菌株的RV3676蛋白质对应物。通过引入对应于BCG点突变的基础变化,降低了M.Tuberculosis RV3676蛋白的DNA结合能力。相反,通过除去突变来恢复BCG RV3676蛋白的BCG RV3676蛋白的DNA结合。这些数据表明,在本报告系统中,BCG中RV3676正原术中存在的点突变菌株使其功能有缺陷(早期菌株)或废除(晚期菌株)并表明该蛋白质在BOOVIS BCG菌株中可能是天然有缺陷的。这提高了BCG菌株衰减的可能性可能是这种全局调节剂的可能性,以控制体内存活和持久性所需的基因的表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号